
Peer-reviewed results from the phase 3 X-TOLE2 trial, published in JAMA Neurology, detail azetukalner's seizure reduction and dose-dependent adverse events in adults with focal epilepsy.
Careful planning and monitoring is important for women with epilepsy who become pregnant. Several studies from AES 2016 address pregnancy issues.
Studies presented at the 2016 American Epilepsy Society Scientific Sessions examined pregnancy issues in women with epilepsy. One study looked at predictors of unintended pregnancy, another discussed antiepileptic drug prescribing patterns, and two studies reported on specific drugs, brivaracetam and lamotrigine, taken during pregnancy.Â

